abstract |
The present invention relates to a nucleic acid molecule capable of binding MCP-1, wherein the nucleic acid molecule is a chronic disease selected from the group consisting of chronic diseases or chronic disorders, preferably chronic respiratory disease, chronic kidney disease and systemic lupus erythematosus. Or for use in a medicament for the treatment and / or prevention of chronic disorders. |